Non-medical users of anabolic steroids often “stack” different anabolic steroids over the course of a “cycle” of use. They also administer various ancillary drugs and substances to enhance the desired effects of anabolic steroids or to minimize adverse side effects. The most common liquid (injectable) anabolic steroids encountered in these cases are (oil-based) esters of testosterone (., testosterone cypionate, testosterone enanthate, and testosterone propionate, and a blend of testosterone esters called Sustanon 250) or nandrolone (., nandrolone decanoate). Also popular are Equipoise (boldenone undecylenate) and trenbolone acetate and trenbolone enanthate, as well as the water-based injectable Winstrol (stanozolol). Popular oral anabolic steroids include methandrostenolone (Dianbol), oxandrolone (Anavar) and oxymetholone (Anadrol 50).
Most drugs of abuse are addictive. Addiction is a chronic, relapsing disease characterized by compulsive drug seeking and use despite negative consequences and by long-lasting changes in the brain. People who are addicted have strong cravings for the drug, making it difficult to stop using. Most drugs alter a person’s thinking and judgment, which can increase the risk of injury or death from drugged driving or infectious diseases (., HIV/AIDS, hepatitis) from unsafe sexual practices or needle sharing. Drug use during pregnancy can lead to neonatal abstinence syndrome, a condition in which a baby can suffer from dependence and withdrawal symptoms after birth. Pregnancy-related issues are listed in the chart below for drugs where there is enough scientific evidence to connect the drug use to negative effects. However, most drugs could potentially harm an unborn baby.
A one-month supply of 600 mg tablets costs approximately $1,010 in July 2016.  In 2007, Merck provided efavirenz in certain developing countries and countries largely affected by HIV for about $ per day.  Some emerging countries have opted to purchase Indian generics.  In Thailand, one month supply of efavirenz + truvada, as of June 2012, costs THB 2900 ($90), and there is a social program for patients who cannot afford the medication. In South Africa, a license has been granted to generics giant Aspen Pharmacare to manufacture, and distribute to Sub-Saharan Africa , a cost-effective antiretroviral drug.